The Last Time This Happened, This Stock Soared 1,000%+

Believe it or not, we now have the best window to buy dividend stocks that we’ve had in decades. Two proven 100%-return indicators just flipped to “green.”

The conditions we’re about to see are rocket fuel for companies growing their dividends like weeds. As usual, we’re going to zig while like-minded money managers (you know, those that outperform a mere index) zag.

Our 100% Proven Contrarian Play

The first factor that points to more upside for stocks is the foul mood among the so-called “smart money.”

According to a June survey by Bank of America Merrill Lynch, fund managers expectations of global growth sank the most since November 1994. What’s more, the pros haven’t been this pouty since, you guessed it, 2008.

So why is this pessimism a bullish indicator? Because the Wall Street whizzes have almost always been dead wrong! 2008 is a great example: if you bought the pros’ sob story then, you’d have missed out on 300% in gains and dividends!

That’s one half of this golden buying opportunity. Here’s the other: the Fed is racing toward a rate cut (and likely more than one).

As I write, 100% of investors betting through the Fed futures market see a rate cut at the Fed’s July 31 meeting, with at least one more likely before New Year’s.

Like July 1995 All Over Again

Here too, history points to a big gain ahead.

Troy Bombardia over at, wrote last week the last time the Fed cut rates while markets soared (which he defines as up 15% or more in the preceding six months), the market caught a further updraft and popped 21.4% one year after the July 1995 cut.

With stocks up 24% in the last six months and rates on the precipice, history looks set to repeat. Which brings me back the two dividend growers I mentioned earlier.

Let’s dive into those now.

Falling-Rate Play No. 1: Crown Castle International (CCI)

Lower rates are a big plus for real estate investment trusts (REITs), for a couple reasons:

  1. REITs’ costs fall, because they carry considerable debt, in the form of mortgages on their properties), plus …
  2. REITs pay big dividends—the Vanguard Real Estate ETF (VNQ) yields 4%, way more than so-called “safe” investments like Treasuries and CDs. And you can bet those dividends will be in high demand as rates fall.

No wonder CCI doubled the market’s gain, with a 411% rise, when rates were at rock bottom following the Great Recession!

CCI pays a 3.4% dividend, well beyond the stream of nickels our safety-obsessed Treasury owners get. But the real story is dividend growth.

When it comes to REIT performance (and dividend safety), we need to look at funds from operations (FFO), a better indicator of profitability than earnings per share (EPS). Right now, CCI’s dividend has lots of room to grow, at just 77% of forecast 2019 adjusted FFO.

“Wait,” you’re probably thinking, “Isn’t 77% a high ratio?”

Not with REITs. Thanks to their steady rental income, any ratio below 90% is just fine. Plus, CCI’s FFO has been surging, and management sees that continuing, with the midpoint of forecast 2019 FFO up 7% from last year’s total.

And this management team isn’t afraid to pull the trigger on a payout hike: they’ve openly stated that their goal is 7% to 8% dividend growth every year. And they’ve more than delivered since the ’09 market bottom!

The upshot here is that CCI will gain no matter what the Fed does: its 40,000 cell towers and 70,000 route miles of fiber-optic cable put it at the forefront of just about every tech megatrend you can name: surging data use, artificial intelligence, connected cars, smart homes—pretty well anything that needs an Internet connection.

That gives CCI the leverage it needs to raise rents on its tenants as current leases expire—and send those increases straight on to you as higher dividends. With the next hike likely in October, CCI is a great stock to add to your summer buy list.

Falling-Rate Play No. 2: Discover Financial Services (DFS)

Discover may seem an odd pick, given the common “wisdom” that lower rates hurt lenders. So let’s take another look at history—this time from the March 2009 market bottom to mid-December 2015.

I know I don’t have to tell you that rates were locked at zero in this period, which should have been a nightmare for Discover shareholders. But they missed that particular memo and banked a 1,000%+ gain instead!

Why? Because DFS is a volume business, and lower rates give the company a tailwind, tempting more people to borrow and spend—and that retail therapy more than offsets a few rate cuts.

The acid test here is that even at today’s rates, Discover’s loan portfolio is ballooning, posting 7% growth in the first quarter, to $88.7 billion. That expansion drove net interest income up a whopping 10%, to $205 million.

Discover yields 2.1%, just above the S&P 500 average, but it pays a minuscule 9.1% of free cash flow as dividends. In other words, management could boost the dividend fivefold tomorrow and still be under the 50% margin of safety I demand in a dividend stock.

Two things stand out: first, DFS is a serial dividend hiker, growing its payout 1,900% since the financial crisis! Second, the stock has paced that payout every single step of the way, until the last year or two, when the dividend pulled ahead.

As I’ve written before, dividend growth is the No. 1 driver of share prices (in fact, as I showed you in my May 28 article, dividend and share price hikes often match each other down to the percentage point in the long haul). So this gap is a great time to move into DFS, before first-level investors realize rate cuts won’t hurt this company one little bit—and bid the stock back up.

Brett Owens is chief investment strategist for Contrarian Outlook. For more great income ideas, click here for his latest report How To Live Off $500,000 Forever: 9 Diversified Plays For 7%+ Income.

Disclosure: none

Articles You May Like

Small business optimism hits 11-year low as inflation fears won’t go away
Fed wants more confidence that inflation is moving toward 2% target, meeting minutes indicate
JPMorgan Chase is set to report first-quarter earnings — here’s what the Street expects
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Top Wall Street analysts like these 3 stocks for their growth prospects

Leave a Reply

Your email address will not be published. Required fields are marked *